Get started
TAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals Bonds

TAK/N chart


Full chart

TAK/N upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪863.45 B‬ MXN
Dividend yield (indicated)
3.98%
Price to earnings Ratio (TTM)
23.37
Basic EPS (TTM)
12.04 MXN
Net income (FY)
‪16.51 B‬ MXN
Revenue (FY)
‪488.67 B‬ MXN
Shares float
‪3.17 B‬
Beta (1Y)
0.01

About TAKEDA PHARMACEUTICAL CO LTD


Sector
Health Technology
CEO
Christophe Weber
Headquarters
Osaka
Website
takeda.com
Founded
1781
FIGI
BBG00N0NV1H3
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

TAK/N news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

TAK/N highest yielding bonds


TKPH5010047
Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050
Yield to maturity
6.70%
Maturity date
Jul 9, 2050
TKPH5010048
Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060
Yield to maturity
6.65%
Maturity date
Jul 9, 2060
TKPH5010046
Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040
Yield to maturity
6.40%
Maturity date
Jul 9, 2040
B
TKPH4369980
Baxalta Incorporated 5.25% 23-JUN-2045
Yield to maturity
5.89%
Maturity date
Jun 23, 2045
TKPH5841810
Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064
Yield to maturity
5.87%
Maturity date
Jul 5, 2064
TKPH5841809
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054
Yield to maturity
5.71%
Maturity date
Jul 5, 2054
TKPH5841808
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044
Yield to maturity
5.63%
Maturity date
Jul 5, 2044
TKPH5010045
Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030
Yield to maturity
5.33%
Maturity date
Mar 31, 2030
TKPH5841807
Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034
Yield to maturity
5.30%
Maturity date
Jul 5, 2034
S
US82481LAD1
SHIRE ACQUIST.I.IE 16/26
Yield to maturity
4.94%
Maturity date
Sep 23, 2026
TKPH4770188
Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028
Yield to maturity
4.84%
Maturity date
Nov 26, 2028

Explore more bonds